Kyntra BioKYNB

13F holders, Q2 2025 (June 30)
29holders
1famous investor
$5.30avg. 13F price*

At the end of Q2 2025, 29 institutions reported holding Kyntra Bio Inc. (KYNB) in their 13F filings. The largest holders were Armistice Capital, LLC ($1.8M), Vanguard Group Inc. ($944K) and Acadian Asset Management LLC ($735K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Kyntra Bio Inc.
Filed as
FIBROGEN INC (Q2 2025)
CUSIP
31572Q881
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q2 2025: 29Q2 2025Q3 2025: 32Q3 2025Q4 2025: 34Q4 2025Q1 2026: 32Q1 2026Q2 2026: 27Q2 2026

Total Exit/New Position Q2 2025

InstitutionsTotal Value
New Positions29$5.5M
Exits0$0

Ownership 29 holders

Armistice Capital, LLC 0.07% New 336,000 $1.8M
Vanguard Group Inc. 0.00% New 178,040 $944K
Acadian Asset Management LLC 0.00% New 139,121 $735K
Primecap Management Co. 0.00% New 89,696 $475K
BlackRock, Inc. 0.00% New 84,751 $449K
Marshall Wace, LLP 0.00% New 72,300 $383K
Geode Capital Management, LLC 0.00% New 44,036 $233K
HighTower Advisors, LLC 0.00% New 39,746 $211K
Two Sigma Investments, LP 0.00% New 14,111 $75K
State Street Corp. 0.00% New 13,719 $73K
Renaissance Technologies 0.00% New 11,181 $59K
UBS Group AG 0.00% New 10,287 $55K
Group One Trading LLC 0.00% New 7,209 $38K
Morgan Stanley 0.00% New 1,660 $9K
Tower Research Capital LLC (TRC) 0.00% New 793 $4K
Osaic Holdings, Inc. 0.00% New 642 $3K
GFG Capital, LLC 0.00% New 507 $3K
Bank of America Corp. 0.00% New 443 $2K
CIBC Private Wealth Group LLC 0.00% New 287 $2K
National Bank of Canada 0.00% New 193 $1K
Royal Bank of Canada 0.00% New 137 $1K
SBI Securities Co., Ltd. 0.00% New 152 $806
BNP Paribas Financial Markets 0.00% New 48 $254
PNC Financial Services Group, Inc. 0.00% New 40 $212
JPMorgan Chase & Co. 0.00% New 12 $64
US Bancorp \de 0.00% New 1 $5
Danske Bank A/S 0.00% New 1 $5
Smithfield Trust Co 0.00% New 1 $0
Cwm, LLC 0.00% New 26 $0

"% of holder's portfolio" is KYNB's weight in each manager's 13F, not the share of Kyntra Bio Inc. the manager owns.